STOCK TITAN

Oxbridge Highlights Strong 2025–26 Performance, Platform Expansion, and Market Opportunity; Reports Q4 and Full-Year Results

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Oxbridge (NASDAQ: OXBR) reported Q4 and full-year results for 2025, highlighting strong tokenized reinsurance performance, platform expansion, and a $6.98M restricted cash position as of December 31, 2025.

Balanced Yield Token is tracking 25% vs 20% target; High Yield Token remains on track for 42%. Company expanded distribution into Solana and across 160+ blockchain networks and prepares T20/T42 offerings for 2026–2027.

Loading...
Loading translation...

Positive

  • Balanced Yield Token tracking 25% return (vs 20% target)
  • High Yield Token on track for 42% target
  • Restricted cash increased to $6.98M as of Dec 31, 2025
  • Platform distribution expanded into Solana and 160+ blockchain networks

Negative

  • Total expenses rose to $6.04M in 2025 from $2.17M in 2024
  • Loss ratio increased to 119.9% for year ended Dec 31, 2025
  • Combined ratio rose to 264.1% for year ended Dec 31, 2025
  • Net loss for 2025 was $2.08M (loss per share $0.28)

Market Reaction – OXBR

+32.58% $1.15 67.9x vol
15m delay 14 alerts
+32.58% Since News
+33.5% Peak in 2 hr 3 min
$1.15 Last Price
$0.84 $1.28 Day Range
+$2M Valuation Impact
$6.66M Market Cap
67.9x Rel. Volume

Following this news, OXBR has gained 32.58%, reflecting a significant positive market reaction. Argus tracked a peak move of +33.5% during the session. Our momentum scanner has triggered 14 alerts so far, indicating notable trading interest and price volatility. The stock is currently trading at $1.15. This price movement has added approximately $2M to the company's valuation. Trading volume is exceptionally heavy at 67.9x the average, suggesting very strong buying interest.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Silver for real-time data.

Key Figures

Balanced Yield Token return: 25% annual return High Yield Token target: 42% annual return Cash and restricted cash: approximately $6.9m +5 more
8 metrics
Balanced Yield Token return 25% annual return 2025–2026 EtaCat Re tracking vs 20% initial target
High Yield Token target 42% annual return ZetaCat Re target for 2025–2026
Cash and restricted cash approximately $6.9m Balance sheet strength highlighted in strategic outlook
Net premiums earned Q4 2025 $555,000 Three months ended December 31, 2025
Net income Q4 2025 $120,000 (EPS $0.02) Versus $460,000 net loss (EPS -$0.05) in Q4 2024
Net loss FY 2025 $2.08 million (EPS -$0.28) Year ended December 31, 2025 vs $2.73m loss in 2024
Loss ratio FY 2025 119.9% Up from 0% in 2024 due to Hurricane Milton losses
Combined ratio FY 2025 264.1% Increased from 94.3% in 2024, reflecting higher losses and expenses

Market Reality Check

Price: $0.8674 Vol: Volume 2,706 is well belo...
low vol
$0.8674 Last Close
Volume Volume 2,706 is well below the 10,420 20-day average ahead of the results release. low
Technical Shares at $0.8674, trading below the $1.56 200-day MA and 69.67% below the 52-week high of $2.86.

Peers on Argus

OXBR slipped 0.22% while peers were mixed: CNFR gained 27.59%, GLRE rose 1.31%, ...

OXBR slipped 0.22% while peers were mixed: CNFR gained 27.59%, GLRE rose 1.31%, FGF fell 9.49%, and HUIZ declined 15.15%. Moves did not align clearly across the group, suggesting a stock-specific backdrop.

Historical Context

5 past events · Latest: Mar 20 (Neutral)
Pattern 5 events
Date Event Sentiment Move Catalyst
Mar 20 Earnings call notice Neutral -2.7% Announcement of date/time for Q4 and full-year 2025 results call.
Mar 12 Distribution expansion Positive +3.7% Expanded T20/T42 token distribution via Alphaledger and LayerZero to 160+ chains.
Mar 12 Distribution expansion Positive +3.7% Further details on LayerZero integration and cross-chain access for offerings.
Feb 10 New token offering Positive +4.5% Launch of 2026–27 T20-2027 and T42-2027 tokenized reinsurance program.
Dec 11 Crypto partnership Positive +2.1% Strategic partnership with Alphaledger to bring RWAs to Solana ecosystem.
Pattern Detected

Recent tokenization and distribution announcements in early 2026 generally coincided with modest positive price reactions, while neutral scheduling news saw mild weakness.

Recent Company History

Over the last several months, Oxbridge has focused heavily on scaling its tokenized reinsurance platform. In Dec 2025, it partnered with Alphaledger to bring high‑yield tokenized reinsurance to Solana, followed by multiple March 12, 2026 releases expanding T20/T42 distribution across 160+ blockchain networks, each met with modest gains of about 3–4%. An earlier Feb 10, 2026 update on solid SurancePlus results and a new 2026–27 offering also saw a positive reaction. A neutral March 20 conference‑call notice drew a small -2.74% move.

Market Pulse Summary

The stock is surging +32.6% following this news. A strong positive reaction aligns with the company’...
Analysis

The stock is surging +32.6% following this news. A strong positive reaction aligns with the company’s emphasis on platform momentum and high targeted returns, including tokens tracking 25% and 42%. Historically, Oxbridge’s tokenization and distribution news around Solana and LayerZero often coincided with modest gains. However, investors would need to weigh the elevated 119.9% loss ratio and 264.1% combined ratio against cash of about $6.9m and improving quarterly profitability.

Key Terms

real-world assets, loss ratio, expense ratio, combined ratio
4 terms
real-world assets financial
"digitizing reinsurance securities as tokenized real-world assets (RWAs)"
Real-world assets are physical or financial things of value—like property, commodities, loans, or art—that exist outside digital markets and can be bought, sold, or used as collateral. For investors, they matter because they often provide steady income, reduce reliance on volatile paper markets, and can add diversification much like owning a rental property beside stock holdings. Treat them like tangible building blocks that can stabilize a portfolio and back the value of financial products.
loss ratio financial
"Loss Ratio. The loss ratio is the ratio of losses and loss adjustment expenses incurred"
Loss ratio is the percentage of an insurer’s collected premiums that is paid out to cover claims and related costs, showing how much of customer payments are used to settle losses. Investors treat it like a fuel-efficiency gauge for an insurance business—lower loss ratios suggest pricing and risk selection leave more room for profit, while consistently high ratios signal weak pricing, rising claims, or not enough money set aside, which can hurt returns.
expense ratio financial
"Expense Ratio. The expense ratio is the ratio of policy acquisition costs and general and administrative expenses"
The expense ratio is the annual fee a mutual fund or exchange-traded fund charges to cover its operating costs, shown as a percentage of the fund’s assets. Think of it like a yearly maintenance or subscription fee that quietly reduces your investment’s returns; even small differences matter over time because the fee compounds against your gains. Investors compare expense ratios to judge how much of their returns will be eaten by fund costs.
combined ratio financial
"Combined ratio. We use the combined ratio to measure our underwriting performance."
The combined ratio is a way insurance companies measure how well they are doing by adding up all their costs and claims and comparing them to the money they earn from premiums. If the ratio is below 100%, it means the company is making a profit; if it's above 100%, they are losing money. It helps see if an insurance company is financially healthy or not.

AI-generated analysis. Not financial advice.

GRAND CAYMAN, Cayman Islands, March 30, 2026 (GLOBE NEWSWIRE) -- Oxbridge Re Holdings Limited (NASDAQ: OXBR), (the “Company”), a leader in digitizing reinsurance securities as tokenized real-world assets (RWAs), together with its subsidiary SurancePlus, today reported its results for the three months and year ended December 31, 2025.

SurancePlus 2025–2026 Tokenized Reinsurance Update

SurancePlus continues to demonstrate strong performance across its 2025–2026 tokenized reinsurance offerings. The Balanced Yield Token (EtaCat Re), which initially targeted a 20% annual return, is now anticipated to achieve a 25% return, and the High Yield Token (ZetaCat Re) remains on track to achieve its 42% return target. These results reflect our portfolio’s disciplined underwriting approach and highlight how tokenized reinsurance can deliver consistent, uncorrelated returns within the $750 billion total addressable reinsurance market.

Platform Expansion and Ecosystem Growth

The Company has advanced the SurancePlus platform through a series of strategic partnerships designed to expand global distribution, infrastructure, and interoperability:

  • We have established a strategic presence in the Solana ecosystem through our partnership with Alphaledger, positioning SurancePlus within one of the leading blockchain platforms for real-world asset adoption, with support from ecosystem participants including the Solana Foundation.
  • Formed a strategic collaboration with LayerZero, enabling distribution of SurancePlus offerings across more than 160 blockchain networks

In parallel, we have increased our targeted marketing and investor engagement initiatives, contributing to growing awareness and expanding participation.

Catastrophe Risk and 2026–2027 Outlook

The Company is preparing for the 2026–2027 contract cycle and its two tokenized reinsurance offerings, T20 and T42, which are targeting an annual return of 20% and 42%, respectively. Industry commentary, including widely followed reporting by Artemis referencing forecasts from AccuWeather, indicates that the 2026 Atlantic hurricane season is expected to be positively influenced by El Niño conditions, which have historically been associated with reduced overall storm activity.

Strategic Outlook

We believe our current market valuation does not fully reflect the strength of our balance sheet, including our approximately $6.9m cash and restricted cash position, the performance of its existing tokenized reinsurance offerings, or the earnings potential of its platform and future opportunities.

Management is also evaluating opportunities to expand the SurancePlus model into additional high-quality, cash-generating assets, including the potential tokenization of data centre revenue streams and other opportunities aligned with the growth of artificial intelligence infrastructure. These initiatives are intended to broaden the Company’s tokenization footprint and support long-term shareholder value creation.

Looking Ahead

The Company remains focused on scaling the SurancePlus platform, expanding global distribution, and executing on its growing pipeline of tokenized real-world asset opportunities.

With strong performance across its current offerings, expanding access through strategic partnerships, and continued innovation in product structure, the Company is well positioned to build on its momentum as it enters the 2026–2027 contract cycle.

Jay Madhu Chairman and CEO commented, “We are pleased with the continued strong performance of our RWA tokenized reinsurance platform, with our Balanced-Yield Token tracking 25%, ahead of its 20% target, and our High-Yield Token tracking its 42% target. As we enter the 2026–2027 contract cycle, we are targeting returns of 20% and 42% for our T20 and T42 offerings.

We have also made meaningful progress expanding our platform, including our entry into the Solana ecosystem and distribution across more than 160 blockchain networks. Looking ahead, we are excited about the upcoming year, including recent reporting from Artemis, indicating El Niño conditions may support a reality of storm numbers being around or even below historical averages.

In parallel, we are evaluating advanced opportunities to extend our model into additional high-quality, cash-generating assets, including the tokenization of data center revenues aligned with the growth of artificial intelligence. We also believe our current market valuation does not fully reflect the strength of our balance sheet, including our cash and restricted position, nor the opportunities we see to drive incremental shareholder value.”

Financial Performance

Net premiums earned for the three months ended December 31, 2025 decreased to $555,000 from $595,000 for the quarter ended December 31, 2024. The decrease is due to lower weighted average rate on reinsurance contracts in force during the quarter ended December 31, 2025, when compared to the prior period.

Net premiums earned for the years ended December 31, 2025 and 2024 was approximately $2.3 million.

Net income for the quarter ended December 31, 2025 was $120,000, or $0.02 basic and diluted income per share compared to a net loss of $460,000, or ($0.05) basic and diluted loss per share, for the quarter ended December 31, 2024. The decrease in net loss is primarily due to the allocation of underwriting losses to tokenholders coupled with a decrease in negative change in fair value of equity securities and unrealized loss on other investments and increase in investment and other income during the quarter ended December 31, 2025 when compared with the prior period.

Net loss for the year ended December 31, 2025 was $2.08 million, or ($0.28) basic and diluted loss per share compared to a net loss of $2.73 million, or ($0.45) basic and diluted loss per share, for the year ended December 31, 2024. The change is primarily due to the higher overall revenues driven by significant decrease in unrealized loss on other investments, partially offset higher expenses and higher underwriting losses borne by tokenholders during the year ended December 31, 2025, when compared with the prior period.

For the three months ended December 31, 2025, total expenses, including policy acquisition costs and general and administrative expenses, increased to $1.04 million from $497,000 for the quarter ended December 31, 2024. The increase is primarily due to the recording of underwriting losses incurred during the quarter as a result of adverse loss development on one of our contracts affected by Hurricane Milton, as well as increased general and admin expenses when compared with the prior period.

For the year ended December 31, 2025, total expenses, including policy acquisition costs, loss and loss adjustment expenses and general and administrative expenses, increased to $6.04 million from $2.17 million for year ended December 31, 2024. The increase is primarily due to the recording of losses on reinsurance contracts, increased professional costs relating to investor relations, our web3 subsidiary tokenization costs, S-3 related costs, increased human resources and personnel costs and legal expenditures.

As of December 31, 2025, our restricted cash and cash equivalents increased by $1.08 million to $6.98 million, from $5.89 million as of December 31, 2024. The increase is primarily due to new collateral deposits for treaty year ending May 31, 2026, more than offsetting funds being released from the underlying trusts for loss payments during 2025 relating to Hurricane Milton. 

Financial Ratios

Loss Ratio. The loss ratio is the ratio of losses and loss adjustment expenses incurred to premiums earned and measures the underwriting profitability of our reinsurance business. The loss ratio increased to 119.9% for the year ended December 31, 2025, from 0% for the year ended December 31, 2024. This was due to the losses recognized on our reinsurance contracts affected by Hurricane Milton.

Acquisition Cost Ratio. The acquisition cost ratio is the ratio of policy acquisition costs and other underwriting expenses to net premiums earned. The acquisition cost ratio measures our operational efficiency in producing, underwriting and administering our reinsurance business. The acquisition cost ratio remained consistent at 11.0% for the year ended December 31, 2025 when compared with the prior comparative period.

Expense Ratio. The expense ratio is the ratio of policy acquisition costs and general and administrative expenses to net premiums earned. We use the expense ratio to measure our operating performance. For the year ended December 31, 2025, the expense ratio increased to 144.2%, from 94.3% for the year ended December 31, 2024. The increase is primarily due to increased professional costs relating to investor relations and our web3 subsidiary marketing and operations, renewed S-3 related costs, increased human resources and personnel costs and legal expenditures during the year ended December 31, 2025, when compared with the prior comparable period.

Combined ratio. We use the combined ratio to measure our underwriting performance. The combined ratio is the sum of the loss ratio and the expense ratio. For the year ended December 31, 2025, the combined ratio increased to 264.1%, from 94.3% for the year ended December 31, 2024. The increase is due to higher general and administrative expenses and the losses incurred during the year ended December 31, 2025, when compared with the prior comparable period.

Conference Call

Management will host a conference call later today to discuss these financial results, followed by a question and answer session. President and Chief Executive Officer Jay Madhu and Chief Financial Officer Wrendon Timothy will host the call starting at 4:30 p.m. Eastern time. The live presentation can be accessed by dialing the number below or by clicking the webcast link available on the Investor Information section of the company’s website at www.oxbridgere.com.

Date: March 30, 2026
Time: 4.30 p.m. Eastern time
Toll-free number: 877-524-8416
International number: +1 412-902-1028

Please call the conference telephone number 15 minutes before the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact InComm Conferencing at +1-201-493-6280
media@incommconferencing.com

A replay of the call will be available by telephone after 4:30 p.m. Eastern time on the same day of the call until April 13, 2026.

Toll-free replay number: 877-660-6853
International replay number: +1-201-612-7415
Conference ID: 13759252

About Oxbridge Re Holdings Limited

Oxbridge Re Holdings Limited (www.OxbridgeRe.com) (NASDAQ: OXBR, OXBRW) (“Oxbridge Re”) is headquartered in the Cayman Islands. The company offers tokenized Real-World Assets (“RWAs”) as tokenized reinsurance securities and reinsurance business solutions to property and casualty insurers, through its wholly owned subsidiaries Oxbridge Reinsurance Limited, Oxbridge Re NS, and SurancePlus Inc.

Insurance businesses in the Gulf Coast region of the United States purchase property and casualty reinsurance through our licensed reinsurers Oxbridge Reinsurance Limited and Oxbridge Re NS.

Our new Web3-focused subsidiary, SurancePlus Inc. (“SurancePlus”), has developed the first “on-chain” reinsurance RWA of its kind to be sponsored by a subsidiary of a publicly traded company. By digitizing interests in reinsurance contracts as on-chain RWAs, SurancePlus has democratized the availability of reinsurance as an alternative investment to both U.S. and non-U.S. investors.

Forward-Looking Statements

This press release may contain forward-looking statements made pursuant to the Private Securities Litigation Reform Act of 1995. Words such as “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project” and other similar words and expressions are intended to signify forward-looking statements. Forward-looking statements are not guarantees of future results and conditions but rather are subject to various risks and uncertainties. A detailed discussion of risks and uncertainties that could cause actual results and events to differ materially from such forward-looking statements is included in the section entitled “Risk Factors” contained in our Form 10-K filed with the Securities and Exchange Commission (“SEC”) on 30th March 2026. The occurrence of any of these risks and uncertainties could have a material adverse effect on the Company’s business, financial condition and results of operations. Any forward-looking statements made in this press release speak only as of the date of this press release and, except as required by law, the Company undertakes no obligation to update any forward-looking statement contained in this press release, even if the Company’s expectations or any related events, conditions or circumstances change.

Company Contact:

Oxbridge Re Holdings Limited
Jay Madhu, CEO
345-749-7570
jmadhu@oxbridgere.com

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
Consolidated Balance Sheets
(expressed in thousands of U.S. Dollars, except per share and share amounts)

  At December 31, 
  2025  2024 
       
Assets        
Investments:        
Equity securities, at fair value (cost: $0 and $1,532)  -   113 
Cash and cash equivalents  268   2,135 
Restricted cash and cash equivalents  6,708   3,758 
Premiums receivable  766   1,059 
Other investments  -   48 
Deferred policy acquisition costs  102   109 
Operating lease right-of-use assets  43   148 
Prepayment and other assets  150   94 
Property and equipment, net  16   1 
Total assets $8,053   7,465 
         
Liabilities and Shareholders’ Equity        
Liabilities:        
         
Reserve for losses and loss adjustment expenses  91   - 
Notes payable to noteholders  118   118 
Losses payable  73   - 
Unearned premiums reserve  926   991 
Operating lease liabilities  43   148 
Accounts payable and other liabilities  309   366 
Total liabilities  1,560   1,623 
         
Mezzanine Equity        
Due to EpsilonCat Re / DeltaCat Re / EtaCat Re / ZetaCat Re Tokenholders  518   1732 
         
Shareholders’ equity:        
Ordinary share capital, (par value $0.001, 500,000,000 shares authorized; 7,664,122 and 6,379,002 shares issued and outstanding)  6   6 
Additional paid-in capital  38,047   34,105 
Accumulated Deficit  (32,137)  (30,163)
Total Oxbridge shareholders’ equity  5,916   3,948 
Non-controlling interests  59   162.00 
Total shareholders’ equity  5,975   4,110 
Total liabilities, mezzanine and shareholders’ equity  8,053   7,465 


OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Consolidated Statements of Operations
(Unaudited)
(expressed in thousands of U.S. Dollars, except per share amounts)

  Three Months Ended  Year Ended 
  December 31,  December 31, 
  2025  2024  2025  2024 
       
Revenue                
Assumed premiums  53   -   2,275   2,379 
Change in unearned premiums reserve  502   595   12   (76)
                 
Net premiums earned  555   595   2,287   2,303 
SurancePlus fee income  -   -   1   312 
Net investment and other income  63   60   314   248 
Realized gain on other investments          35   - 
Interest and gain on redemption of Series A-1 preferred shares  -   47   -   47 
Interest and gain on redemption of loan receivable  -   -   -   41 
Unrealized loss on other investments  -   (208)  (20)  (2,145)
Change in fair value of equity securities  (42)  (72)  (40)  (260)
                 
Total revenue $576   422  $2,577   546 
                 
Expenses                
Losses and loss adjustment expenses  449   -   2,742   - 
Policy acquisition costs and underwriting expenses  61   66   252   254 
General and administrative expenses  531   431   3,046   1,917 
                 
Total expenses $1,041   497  $6,040   2,171 
                 
Loss before loss (income) attributable to tokenholders and non-controlling interests  (465)  (75)  (3,463)  (1,625)
Loss (income) attributable to tokenholders  689   (246)  1,386   (962)
Income (loss) before income attributable to non-controlling interests  224   (321)  (2,077)  (2,587)
Income attributable to non-controlling interests  (104)  (139)  (2)  (139)
                 
Net income (loss) attributable to ordinary shareholders  120   (460)  (2,079)  (2,726)
                 
Loss per share attributable to ordinary shareholders                
Basic and Diluted  0.02   (0.05)  (0.28)  (0.45)
                 
Weighted-average shares outstanding                
Basic and Diluted  7,664,122   6,121,020   7,389,822   6,099,051 
                 
Performance ratios to net premiums earned:                
Loss ratio  80.9%  0.0%  119.9%  0.0%
Acquisition cost ratio  11.0%  11.1%  11.0%  11.0%
Expense ratio  106.7%  83.5%  144.2%  94.3%
Combined ratio  187.6%  83.5%  264.1%  94.3%



FAQ

What did Oxbridge (OXBR) report for its Balanced Yield Token performance in 2025?

The Balanced Yield Token is tracking a 25% return, exceeding its 20% target. According to the company, disciplined underwriting drove this outcome and the token is part of its broader SurancePlus tokenized reinsurance platform expansion.

How did Oxbridge (OXBR) perform financially for the year ended December 31, 2025?

Oxbridge reported a $2.08M net loss for 2025, or ($0.28) per share. According to the company, higher expenses and underwriting losses related to Hurricane Milton drove increased losses despite higher overall revenues.

What material expense and underwriting changes did Oxbridge (OXBR) disclose for 2025?

Total expenses rose to $6.04M in 2025 from $2.17M in 2024, and the loss ratio reached 119.9%. According to the company, underwriting losses and higher professional and operating costs explain the increases.

What platform and distribution expansions did Oxbridge (OXBR) announce on March 30, 2026?

Oxbridge expanded SurancePlus into the Solana ecosystem and enabled distribution across 160+ blockchain networks. According to the company, partnerships with Alphaledger and LayerZero support broader global distribution and interoperability.

What are Oxbridge's target returns for the 2026–2027 tokenized reinsurance offerings T20 and T42?

Oxbridge targets annual returns of 20% for T20 and 42% for T42 for the 2026–2027 contract cycle. According to the company, these targets reflect continuity with prior tokenized offering structures and performance goals.
Oxbridge Re Hldgs Ltd

NASDAQ:OXBR

View OXBR Stock Overview

OXBR Rankings

OXBR Latest News

OXBR Latest SEC Filings

OXBR Stock Data

6.82M
6.46M
Insurance - Reinsurance
Fire, Marine & Casualty Insurance
Link
Cayman Islands
GEORGETOWN